Skip to main content

Together we are beating cancer

Donate now

Non small cell lung cancer

Showing 12 out of 49 results
Lung cancer cells seen through a microscope.
  • Science & Technology
  • Health & Medicine

ASCO 2023 roundup: Blood tests, drugs and exercise

ASCO’s annual meeting is the world’s biggest cancer conference. This year’s highlights included updates on cancer blood tests, AI tools for estimating cancer risk, better drugs for some lung and ovarian cancers, and interesting data on how yoga can help patients. ASCO’s annual meeting is the world’s biggest cancer conference. This year’s highlights included updates on cancer blood tests, AI tools for estimating cancer risk, better drugs for some lung and ovarian cancers, and interesting data on how yoga can help patients.

12 June 2023

Lung adenocarcinoma cells

Researchers have developed a new model to study senescence in, and found that clearing a certain type of senescent cell from the tumour microenvironment could prevent some lung cancers. Researchers have developed a new model to study senescence in, and found that clearing a certain type of senescent cell from the tumour microenvironment could prevent some lung cancers.

by Jacob Smith | Analysis | 1 June 2023

1 June 2023

Non small cell lung cancer cells stained in pleural effusion sample.

Researchers based at the Francis Crick Institute have published new results from TRACERx, revealing the secrets of how lung cancer can evolve, spread and resist treatment. Researchers based at the Francis Crick Institute have published new results from TRACERx, revealing the secrets of how lung cancer can evolve, spread and resist treatment.

by Jacob Smith | Analysis | 12 April 2023

12 April 2023

A photograph of a person holding a blood test

Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test. Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.

by Graeme Sneddon | News | 1 April 2022

1 April 2022

3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer. 3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer.

by Harry Jenkins | News | 19 January 2022

19 January 2022

Non small cell lung cancer cells stained in pleural effusion sample.

A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE). A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE).

by Harry Jenkins | News | 12 January 2022

12 January 2022

Lung cancer cell

More than 600 people in England with a form of lung cancer could benefit from the innovative drug osimertinib (Tagrisso) after its approval by the National Institute for Health and Care Excellence. More than 600 people in England with a form of lung cancer could benefit from the innovative drug osimertinib (Tagrisso) after its approval by the National Institute for Health and Care Excellence.

by Harry Jenkins | News | 1 December 2021

1 December 2021

Lung cancer cells

Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected. Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected.

by Harry Jenkins | News | 11 November 2021

11 November 2021

Lung adenocarcinoma cells
  • Science & Technology
  • Health & Medicine

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented. One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented.

by Harry Jenkins | Analysis | 9 June 2021

9 June 2021